Posters
« Back
Intraoperative Hemostatic Management of A Patient with type 3 vWD Undergoing CABG
EP28795
Intraoperative Hemostatic Management of A Patient with type 3 vWD Undergoing CABG
Submitted on 09 Jul 2018

Darius Jamschidian, MD, Surbhi Mathur, MBBS, Timothy Del Rosario, MD, Ankit Jain, MBBS
Anesthesiology and Perioperative Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia
This poster was presented at Georgia Society of Anesthesiologist
Poster Views: 171
View poster »
Poster Abstract
Open heart surgery is a major challenge in patients suffering from inherited bleeding disorders such as von Willebrand Disease.
Here we describe the intraoperative hemostatic management of a 73-year-old Caucasian male with a history of vWD who was found to have significant multi-vessel coronary artery disease and underwent cardiothoracic surgery for open revascularization.
Arriving at a specific diagnosis of vWD was crucial in formulating a perioperative strategy. The approach in this setting was to optimize vWF and FVIII levels in the preoperative, intraoperative, as well as postoperative periods. The administration of Humate P was also central to this plan.
Throughout the case, no significant bleeding of any type was observed and the postoperative course was unremarkable. The patient was discharged on postoperative day 8.


1. Veyradier A, Jenkins CS, Fressinaud E, Meyer D. Acquired von Willebrand syndrome: from patho-physiology to management. Thromb Haemost 2000;84:175-182
2. Teppone-Martin OL, Zhao M, Norris TE. von Willebrand disease and cardiopulmonary bypass: a case report. AANA J 2013;81:60-64
3. Lee JW. von Willebrand disease, hemophilia A and B, and other factor deficiencies. Int Anesthesiol Clin. 2004;42(3):59-76
4. Federici AB. The safety of plasma-derived von Willebrand/factor VIII concentrates in the management of inherited von Willebrand disease. Expert Opin Drug Saf. 2009;8(2):203-210
5. Mannucci PM, Cattaneo M. Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease. Haemostasis 1992;22:276-280
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


PROPIEDADES FISICOQUIMICAS DE ALMIDONES DE YUCA MODIFICADOS MEDIANTE OXIDACION CON OZONO
Andrea Saavedra; Guillermo Salamanca Grosso; Izabel Cristina Moraes F.

The EurOPDX EDIReX project: towards a European Research Infrastructure on patient-derived cancer models
E. Vinolo 1, J.P. Morris 1, D.G. Alférez 2, J. Arribas 3,4,5, C. Bernadó 3,4,5, A. Bertotti 6, A. Bruna 7, A.T. Byrne 8, C. Caldas 7, R.B. Clarke 2, N. Conte 9, R. Corsi 10, S. Corso 6, M. Crespo 3, A. Dahmani 11, V. Dangles-Marie 11, D. Decaudin 11, Z. Dudová 12, A. Fiori 6, S. Giordano 6, M. Hauptsmann 13, M. Hidalgo 14, C. Isella 6, S. de Jong 15, J. Jonkers 13, A. Křenek 12, O. Krijgsman 13, D. Kouřil 12, J.C. Lacal 14, L. Lanfrancone 16, E. Leucci 17, G.M. Mælandsmo 18, E. Marangoni 11, J. Mason 9, M.Th. Mayrhofer 19, A. Mazzocca 6, T.S. Meehan 9, E. Montaudon 11, F. Nem

Outcomes of prolotherapy for intra-tendinous Achilles tears: A case series
Ben Havard, Otto Chan, Dylan Morrissey, Sarah Morton

computed tomography differentiation of primary pulmonary lymphoepithelioma-like carcinoma and small cell lung cancer
Kang-Lung, Lee; Mei-Han, Wu; Chun-Ku, Chen; Ying-Yu, Jhang; Yi-Chun, Chen

Trauma CT Explodes in Birmingham (2016-2018)
JP Jen, S Hussain